IOG - Institute of Oncology of Guarulhos Competitors and Similar CompaniesClear all

IOG - Institute of Oncology of Guarulhos's competitors and similar companies include Devyser, Waratah Private Hospital, Barnaclínic + and AMLo Biosciences.
IOG - Institute of Oncology of Guarulhos
IOG - Institute of Oncology of Guarulhos
IOG - Institute of Oncology of Guarulhos is a healthcare center specializing in oncology diagnosis.
Devyser
Devyser
Devyser is a company that specializes in the development, and sales of diagnostic kits for complex DNA testing within oncology.
Waratah Private Hospital
Waratah Private Hospital
Waratah Private Hospital is a health care services provider.
Barnaclínic +
Barnaclínic +
Barnaclínic + is a clinic that provides healthcare solutions.
AMLo Biosciences
AMLo Biosciences
AMLo Biosciences is a company that develops a prognostic test for early-stage cutaneous melanoma.
Founding Date
Founding Date
1996
Founding Date
2004
Founding Date
2012
Founding Date
N/A
Founding Date
2017
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
BR HQ
Locations
Hägersten, SE HQ
Butzbach, DE
Firenze, IT
Locations
Sydney, AU HQ
Locations
Barcelona, ES HQ
Locations
Newcastle upon Tyne, GB HQ
Newcastle Upon Tyne, GB
Newcastle Upon Tyne, GB
Employees
Employees
393% increase
Employees
1281% increase
Employees
1184% increase
Employees
901% decrease
Employees
209% decrease
For sources of this data, please see the company profile

View Company Profiles

Devyser
HQ
Hägersten, SE
Employees
128↑ 1% increase

Devyser is a company that specializes in the development, and sales of diagnostic kits for complex DNA testing within oncology.

View company
Waratah Private Hospital
HQ
Sydney, AU
Employees
118↑ 4% increase

Waratah Private Hospital is a health care services provider.

View company
Barnaclínic +
HQ
Barcelona, ES
Employees
90↓ 1% decrease

Barnaclínic + is a clinic that provides healthcare solutions.

View company
AMLo Biosciences
HQ
Newcastle upon Tyne, GB
Employees
20↓ 9% decrease

AMLo Biosciences is a company that develops a prognostic test for early-stage cutaneous melanoma.

View company